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Abstract
BACKGROUND: Because insulin signaling is essential for endothelial nitric oxide synthase 
(eNOS)-derived nitric oxide (NO) production, loss of bioavailable NO might be a common 
underlying molecular mechanism for the development of insulin resistance and endothelial 
dysfunction. Although dietary nitrite act as a substrate for systemic NO generation, serving as 
physiological alternative source of NO-based signaling, it is not known how dietary nitrite affects 
type 2 diabetes mellitus. We report therapeutic effects of dietary nitrite on the metabolic and 
histological features of KKAy diabetic mice.
METHODS: KKAy mice were divided into 3 groups (without nitrite, 50 mg/L, and 150 mg/L 
nitrite in drinking water), and 2 groups of C57BL/6J as controls (without nitrite and 150 mg/L nitrite 
in drinking water). After 10 weeks, blood samples, visceral adipose tissues and gastrocnemius
muscles were collected following 16 hours fasting for the assessment of homeostasis model 
assessment of insulin resistance (HOMA-IR), histology of adipose tissue, insulin-stimulated 
sequential signaling to glucose transporter 4 (GLUT4), and nitrite and nitrate contents in the muscle
using HPLC system.
RESULTS: KKAy mice developed obesity with enhanced fasting plasma levels of glucose and 
insulin, and exhibited increased HOMA-IR score compared to C57BL/6J control mice. Dietary 
nitrite dose-dependently reduced the size of hypertrophic adipocytes and TNF-α transcription in the 
adipose tissue of KKAy diabetic mice, which also restored insulin-mediated signal transduction 
including p85 and Akt phosphorylation and subsequent GLUT4 expression in skeletal muscles.
CONCLUSIONS: These results suggest that dietary nitrite provides an alternative source of NO, 
and subsequently improving insulin-mediated signaling pathway and the metabolic and histological 
features in KKAy diabetic mice.
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1. Introduction
  Insulin affects cells through binding to its receptor on the surface of insulin-responsive cells
regulating glucose homeostasis. In addition, the signaling pathway linking the insulin receptor to 
activation of endothelial nitric oxide synthase (eNOS) in vascular endothelium also has been 
recognized (Abel 2004, Lundberg 2009, Das 2003, Wang 2013). Therefore, there is reciprocal 
relationship between insulin resistance and endothelial dysfunction in the pathophysiology 
underlying diabetes and metabolic syndrome (Kim 2006). Recent accumulating evidence has 
suggested that polymorphism in the eNOS gene is associated with development of metabolic 
syndrome in humans (Fernandez ML 2004, Monti LD 2003), and eNOS-deficient mice display a 
number of features of metabolic syndrome characterized by hypertension, dyslipidemia, and insulin 
resistance (Gonzalez-Sánchez 2007, Duplain 2001), indicating that loss of bioavailable nitric oxide 
(NO) might be a common underlying molecular mechanism for the development of metabolic 
syndrome and insulin resistance (Sansbury 2014). It would be therefore reasonable to consider 
exogenous NO donor as a pharmacologic agent for the prevention and treatment of type 2 diabetes 
mellitus. 
  It is well accepted that dietary nitrate and nitrite act as a substrate for systemic NO generation, 
serving as physiological alternative source of NO-based signaling especially when endogenous 
NOS-derived NO is lacking (Bryan NS 2005). However, there are few reports showing beneficial 
effects of dietary nitrite/nitrate on type 2 diabetes mellitus (Carlstrom 2010, Mohler 2014). In the 
present study, first we characterized KKAy mice as type 2 diabetic animal model in comparison to 
C57BL/6J control mice in terms of insulin resistance, visceral adipose tissues and insulin-stimulated 
signaling process to glucose transporter 4 (GLUT4) expression. We then sought to investigate 
whether dietary nitrite supplementation would reverse the metabolic and histological features of 
KKAy diabetic mice and consequently improve insulin resistance.
2. Material and methods
2-1. Animals
Specific pathogen-free male KKAy and C57BL/6J mice, 3 week of age from CLEA Japan, Inc. 
(Tokyo, Japan) were allowed food (CE-2, CLEA Japan) and reverse osmosis (RO) water ad libitum, 
and were kept on a 12/12 h light/dark cycle with at least 7 days of local vivarium acclimatization 
before experimental use. All the protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Josai Life Science Center (H22040) and were consistent with the 
Guide for the Care and Use of Laboratory Animals published by the NIH.
2-2. Experimental procedures
Starting at 4 weeks of age, KKAy mice were divided into 3 groups: without nitrite (KKAy-0mg/L , 
n=10), 50 mg/L (KKAy-50mg/L, n=10), and 150 mg/L nitrite (KKAy-150mg/L, n=10) in drinking 
water, 2 groups of C57BL/6J as controls: without nitrite (C57BL/6J-0mg/L, n=8) and 150 mg/L 
nitrite (C57BL/6J-150mg/L, n=8) in drinking water. The mice were housed in individual cages in a 
temperature- and humidity controlled room. Obesity was confirmed by checking body weight (once 
at a week), food intake (once at a week) and casual blood glucose levels (once at 2 weeks) for 10 
week experimental periods. Casual blood glucose levels were determined with GlucocardTM
(GT-1661, Arkray, Inc., Kyoto, Japan). Blood samples were obtained from the cut tip of the tail. 
At 13 weeks of age, intraperitoneal glucose tolerance tests (IPGTT) were performed. Following 
overnight fast, animals were administered intraperitoneal dose of 20% glucose solution (1.5 g/kg). 
Blood samples were collected from tail vein before and 15, 30, 60, 90, 120 min after injection. 
At 14 weeks of age, the animals were anesthetized with an intraperitoneal injection of 
pentobarbital (60mg/kg) following 16 hours fasting period. To determine the homeostasis model 
assessment as an index of insulin resistance (HOMA-IR), blood samples (about 200 L) were 
collected from tail vein before necropsy. Blood glucose levels were determined with GlucocardTM
(GT-1661, Arkray, Inc., Kyoto, Japan). Plasma insulin concentrations were determined with Mouse 
Insulin ELISA kit (Shibayagi, Gunma, Japan). HOMA-IR was calculated as fasting plasma glucose 
[mmol/l] × fasting plasma insulin [mU/l] / 22.5 (Liu 2010). Thereafter, animals were 
intraperitoneally administered insulin (10 U/kg, diluted in saline). This produced a maximal 
sustained increase in IR, IRS-1, and p85 phosphorylation within 5 min (Ishizuka 1999). At 5 min 
after injection, Gastrocnemius muscles and visceral adipose tissues were then excised from insulin 
injected animals and frozen immediately at -80°C until use. Visceral adipose tissues were weighed 
and stored at −80°C until use or fixed in 10% (w/v) neutral buffered formalin solution.
2-3. RT-PCR
Adipose tissue samples stored at −80°C were extracted using RNeasy Lipid Tissue Mini kit 
(QIAGEN) according to the manufacturer's instructions. Total RNA concentrations were quantified 
by NanoDrop (Thermo Fisher ScientificTM). RT-PCR was performed with 1 g of total RNA by use 
of Gene RED PCR Mix (NIPPON GENE) according to the manufacturer's instructions: 1 cycle at 
42°C for 40 min, 95°C for 5 min, and 4°C for 5 min for reverse transcription; and 22-34 cycles at 
94°C for 30 s, 60°C for 30 s, and 72°C for 1 min for PCR. PCR was performed with a RoboCycler 
96 gradient temperature cycler (Stratagene). The oligonucleotides used as primers were synthesized 
by FASMAC (Kanagawa, Japan). The primer pairs were designed as follows, GAPDH: forward 
primer, 5′-agaacatcatccctgcatcc′,reverse primer, 5′-tccaccaccctgttgctgta-3′ (367 bp, 22 cycle), 
TNF-: forward primer, 5 ′ -ggcaggtctactttggagtcattgc ′ , reverse primer, 5 ′
-acattcgaggctccagtgaattcgg-3 ′ (300 bp, 34 cycle), MCP-1: forward primer, 5 ′
-actgaagccagctctctcttcctc′, reverse primer, 5′-ttccttcttggggtcagcacagac-3′ (274 bp, 28 cycle). 
Target mRNA expressions were quantified relative to the expression of GAPDH. A portion of each 
PCR mixture was electrophoresed in 2% agarose gel in TBE buffer (89 mM Tris, 89 mM boric acid, 
2 mM EDTA, pH 8.3), and the gel was visualized by ethidium bromide staining. The intensity of the 
PCR products was measured using a Gene Genius Bioimaging System (Syngene).
2-4. Histological analysis
Adipose tissues were fixed in 10% neutral buffered formalin solution and embedded in paraffin. 
Sections (8 μm) were stained with hematoxylin and eosin (HE) for light microscopic observation at 
magnification×200. The area and size distribution of adipocyte were measured in 500 cells/20 fields 
/ mouse (n=4/groups) using the Image J software program (Okuno 1998). Digital images were 
obtained from a high-resolution digital camera system (Penguin 150CL, Pixera, Los Gatos, CA, 
USA) linked to a microscope (BX41, Olympus, Tokyo, Japan) and desktop computer (Pentium 4, 2.0 
GHz).
2-5. Western blot analysis
The plasma membrane fraction (used for detecting GLUT4 translocation) and tissue lysate (used 
for detecting PI3/Akt signaling) were prepared from skeletal muscle as described previously (Dang 
2010). Briefly, tissue samples were homogenized in 10 volumes of ice-cold lysis buffer A (10 mM 
Tris-HCl at pH 7.8, 10 mM KCl, 1.5 mM MgCl2, 1 mM phenylmethylsulfonylfluoride, 0.5 mM 
dithiothreitol, 5 g/mL of aprotinin and 10 g/mL of leupeptin) and lysed with 10 volumes of buffer 
A with 0.1% Nonidet P-40, and passed through a 22-gauge needle three times. The homogenate was 
spun at 1,000g for 10 min at 4ºC. The plasma membrane fraction was obtained by resuspending the 
obtained pellet in buffer A containing 1% Nonidet P-40, and centrifuging at 100,00g for 20 min at 
4ºC. To obtain the whole tissue lysate, skeletal muscle was homogenized in 10 volumes of buffer A 
and lysed with 10 volumes of buffer B (10 mM Tris-HCl at pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 
0.5% sodium deoxycholate, 0.1% SDS, 0.5 mM DTT, 1 mM phenylmethylsulfonylfluoride, 0.5 mM 
dithiothreitol, 5 g/mL of aprotinin and 10 g/mL of leupeptin). Both the plasma membrane fraction 
and the whole tissue lysates typically contained 4 mg protein per ml on the basis of the BCA protein 
assay. Protein samples (20 μg protein/lane) were resolved by SDS–PAGE, electroblotted to PVDF 
membranes, and immunoblotted with selected antibodies against PI3 kinase p85 (Cell Signaling 
Technology), p85-Tyr458 (Cell Signaling Technology), Akt (Cell Signaling Technology), Akt-Ser473
(Cell Signaling Technology), GLUT4 (Santa Cruz Biotechnology), GAPDH (Santa Cruz 
Biotechnology). Bound antibody was visualized using the ECL chemiluminescence detection system 
(SuperSignal West Dura Extended Duration Substrate, Pierce) with HRP-conjugated secondary 
antibodies (Pierce). The band intensity was quantified using a Bio Imaging System, with Gene Snap 
and Gene Tools software (Syngene Bio Imaging, Cambridge, USA). 
                            
2-6. Nitrite and nitrate concentrations in the skeletal muscle
Nitrite and nitrate concentrations in the skeletal muscle were measured using a dedicated HPLC 
system (ENO-20; EiCom, Kyoto, Japan) (Ohtake 2007, Ohtake 2010). This method is based on the 
separation of nitrite and nitrate by ion chromatography, followed by on-line reduction of nitrate to 
nitrite, postcolumn derivatization with Griess reagent, and detection at 540 nm. Proteins in each 
sample were removed by centrifugation at 10,000g for 5 min following methanol precipitation 
(muscle:methanol = 1:2 weight/volume, 4 °C).
2-7. Statistical analysis
All values are expressed as means ± SE. Data were analyzed by two-way ANOVA, and then 
differences among means were analyzed using the Tukey–Kramer multiple comparison test. A level 
of P < 0.05 was considered significant.
3. Results
3.1. Time course of changes in body weight, food intake, and fasting blood glucose levels
  In comparison to C57BL/6J groups, KKAy groups showed remarkable increases in body weight, 
food intake and casual blood glucose levels at the designated time points over the course of the study 
(Fig. 1a-c), presenting the characteristic features of type 2 diabetes such as obesity and 
hyperglycemia. Whereas, nitrite treatment had no impact on the changes in body weight, food intake 
and casual blood glucose levels either in KKAy groups or in C57BL/6J groups. 
3.2. Effects of dietary nitrite on glucose metabolism and insulin sensitivity
Figure 2a shows the time course of blood glucose levels following IPGTT performed at the end of 
the experimental day after 16 hours fasting. The blood glucose levels of KKAy groups were 
significantly higher than C57BL/6J groups from 30min to 120 min after IPGTT, showing impaired 
glucose tolerance, however among KKAy groups there was a tendency of decrease in blood glucose 
levels in KKAy-150 compared to KKAy-0 at each time period (statistically significant at 90 min). 
Similarly, the AUC (area of the glucose metabolic clearance rate following IPGTT) of KKAy-0 was 
more than C57BL/6J control groups, and apparently reduced with dietary nitrite in KKAy-150 group 
(Fig. 2b). We also measured HOMA-IR calculated from the fasting plasma levels of glucose and 
insulin (Fig. 3a and b). Consistent with the results of IPGTT, HOMA-IR exhibited insulin resistance 
in KKAy-0 group, which was improved with dietary nitrite both in KKAy-50 and -150 (Fig. 3c). 
3.3. Effects of dietary nitrite on the adipose tissue morphology
  We next investigated the effect of dietary nitrite on the adipose tissue mass and the size of 
adipocytes in KKAy mice. The ratio of adipose tissue mass to body weight was significantly higher
in KKAy groups than C65BL/6J groups (Fig. 4a), while dietary nitrite had no impact on this ratio 
either in KKAy or in C65BL/6J group. On the other hand, histological analyses of fat tissue revealed 
that adipocyte size of KKAy-0 was larger than that of C57BL/6J groups and dose-dependently
reduced with dietary nitrite in KKAy-50 and -150 groups (Fig. 4b). Qualitative analysis of adipocyte 
size revealed a wide distribution of cell frequency and tendency to spread toward the larger sizes in 
KKAy-0 group, while comparing with KKAy-0 group, the analysis showed an increasing frequency
of small adipocytes (area<10,000μm2) and decreasing wide distribution of larger adipocytes (area 
>10,000μm2) in KKAy-50 and -150 groups (Fig. 4c).
3.4. Effects of dietary nitrite on the transcription of proinflammatory cytokines in visceral fat tissues
We examined the relation of hypertrophic phenotype change of adipocyte to proinflammatory state 
of fat tissue and also examined the anti-inflammatory effect of dietary nitrite. Unfortunately we could 
not observe a significant suppression of the transcriptional level of MCP-1 (Fig. 5a), whereas dietary 
nitrite obviously reduced the transcriptional level of TNF-α in adipose tissue (Fig. 5b).
3.5. Sequential phosphorylation of p85/Akt and subsequent expression of GLUT4 on the cell 
membrane of skeletal muscle
We then evaluated the effect of dietary nitrite on the PI3K-Akt-GLUT4 signaling pathway (insulin
receptor-mediated signaling pathway) in skeletal muscle. In figure 6, the upper panels show Western 
blots of each signaling protein (data are representative of three independent experiments). The band 
intensities were quantified by densitometry, and the ratios of the levels of phosphorylated to total 
protein were determined as p85-Tyr458 to p85 (Fig. 6a) and Akt-Ser473 to Akt (Fig. 6b), and the ratio 
of the expression level of GLUT4 to housekeeping protein GAPDH was also determined as GLUT4
to GAPDH (Fig. 6c). Despite no statistical difference in p85 phosphorylation among KKAy groups 
(Fig. 6a), dietary nitrite exhibited a tendency to increase the insulin-stimulated phosphorylation of 
the regulatory p85 subunit of PI3K compared to untreated KKAy-0 group and this increasing 
tendency was significantly amplified in the subsequent Akt phosphorylation of KKAy-50 and -150 
groups with dietary nitrite (Fig. 6b), and which was followed by the increase in GLUT4 expression 
on cell membrane of skeletal muscle (Fig. 6c).
3.6. Nitrite and nitrate levels in skeletal muscle
Because it is difficult to measure NO production directly in vivo, we instead measured skeletal 
muscle levels of nitrite and nitrate (stable NO oxidation products indicative of the level of 
accumulated NO production in the fasting condition) after 16 hours fasting. Interestingly, tissue 
levels of nitrite (immediate NO oxidation product) in non-treated KKAy mice was significantly 
lower than C57BL/6J control mice, suggesting reduced NO production and bioavailability in diabetic 
state. However, dietary nitrite improved insulin resistance by restoring tissue levels of nitrite and 
nitrate (Fig. 7).
4. Discussion
  Adipose tissue is necessary for normal secretion of adipokines such as leptin and adiponectin 
which enhance insulin sensitivity. Impaired secretion of such adipokines observed in lipodystrophy 
of human and mouse raises plasma levels of TG and FFAs, causing insulin resistance (Guerre-Millo
2004). On the contrary, enlarged adipocyte in obesity produces another kind of adipokines such as 
MCP-1 and TNF-α, which increase lipolysis in adipose tissues and release FFAs into the circulation, 
finally leading to insulin resistance and type 2 diabetes mellitus. 
In the present study, as increased adiposity develops in KKAy diabetic mice (Fig 4a, b), the 
transcriptional levels of MCP-1 and TNF-α become higher in adipocytes of KKAy-0 mice than 
C57BL/6J control mice (Fig 5a, b). We qualitatively analyzed the sizes of adipocyte using the 
histogram of cell size distribution, which revealed a wider distribution of cell frequency and a 
tendency to spread toward the larger sizes in KKAy-0 group than in C57BL/6J control mice, the cells 
of which were mainly composed of small adipocytes (Fig. 4c). The phenotypic changes of adipocytes 
in the diabetic mice are closely associated with the increased transcriptional levels of MCP-1 and 
TNF-α in adipocytes (Fig. 5). These proinflammatory cytokines and FFAs modulate systemic 
inflammatory responses through the TLR4-mediated mechanism (Reyna 2008). It is well known that 
TLR4-mediated NF-κB activation is inhibited by NO via S-nitrosylation of cysteine residue of Ikkβ
and NF-kB itself, which thereby causes inhibition of IκBα phosphorylation and NF-kB binding to 
DNA, respectively (Hess 2005). Then, this could inhibit transcription of the inflammatory cytokines 
including MCP-1 and TNF-α in adipocytes (Fig. 5a, b). Similarly in the present study, dietary nitrite 
dose-dependently shifted the cell frequency to the smaller size distribution in KKAy diabetic mice 
(Fig. 4c), which is obviously consistent with the decrease in TNF-α transcription in adipose tissues 
with dietary nitrite. 
As increased adiposity is supposed to be a cause of subsequent systemic inflammation, it causes
excessive ROS production and oxidative shift in the intracellular redox environments (de Luca 2008). 
Recent evidence indicated that the defect responsible for insulin resistance lies mostly at the 
post-receptor level of insulin signaling (Draznin 2006). Because many kinases and phosphatases 
associated with insulin signaling pathway are intricately, but delicately regulated and balanced by 
protein phosphorylation, dephosphorylation, and in addition, nitrosylation (Fisher-Wellman 2012). 
Excessive NO production by iNOS S-nitrosylates the proteins such as IRS-1 and Akt involved in the 
early steps of the insulin transduction pathway, and this results in insulin resistance in skeletal 
muscle (Carvalho-Filho 2005). On the other hand, physiological levels of NO not only induces
microvascular vasodilatation for the effective insulin transport to the target cells, but also mediates 
S-nitrosylation of protein-tyrosine phosphatase 1B (PTPB1) (Wang 2013) and enhancing insulin 
action. Because PTPB1 dephosphorylates insulin receptor and its substrates, then attenuating insulin 
action, its phosphatase activity usually tends to be suppressed by eNOS-mediated S-nitrosylation.
Whereas once vascular eNOS activity is impaired as seen in diabetes and metabolic syndrome, 
PTPB1 suppresses the downstream signaling to PKB/Akt, then leading to insulin resistance. Thus, 
NO might act as a regulating factor for the downstream signaling linking to GLUT4 translocation 
and glucose uptake (Hsu 2010, Richey 2013). In addition, as shown in the present study, Jiang 
recently reported the GLUT4-mediated mechanism in dietary nitrite-induced improvement of insulin 
resistance, in which they demonstrated that NO-dependent nitrosylation of GLUT4 itself facilitates 
GLUT4 translocation to the membrane for glucose uptake and thereby improving insulin resistance 
(Jiang 2014). In the present study we have not examined nitrosative modification of these 
signal-related proteins and the evidence concerning these issues so far remains poor, but this might 
be a possible mechanism by which dietary nitrite consequently recover the insulin-stimulated 
phosphorylation of the p85 and Akt as well as the expression of GLUT4 and glucose metabolism in 
the skeletal muscles (Fig 6 a-c).
In addition to the NO-mediated mechanisms mentioned above, NO is also reported to play
important roles in the suppression of the development of insulin resistance at various levels and 
conditions including mitochondrial function (Larsen 2011), insulin secretion (Nystrom 2012), insulin 
transport (Wang 2013), glucose uptake (Khoo 2014), and modulation of inflammation (Rizzo 2010). 
Recent accumulating data has indicated that loss of NO bioavailability might be a pivotal underlying 
molecular mechanism for the development of insulin resistance (Carlstrom 2010, Kashyap 2005). In 
agreement with these proposals, the present study also showed a significant decrease in the nitrite 
levels in the skeletal muscle of KKAy diabetic mice compared to C57BL/6J control mice (Fig. 7), 
suggesting that the decrease in NO bioavailability in the skeletal muscle of the diabetic mice is also 
observed in the present study. Dietary nitrite supplementation increases the nitrite levels of skeletal 
muscle, then contributing to the subsequent improvements of the metabolic and histological features 
of KKAy diabetic mice.
To apply this strategy to the clinical setting, we also have to consider the food sources of 
nitrate/nitrite. According to the report by Hord (Hord 2009) in which daily nitrate intakes were 
calculated based on the variations by using the vegetable and fruit components of the Dietary 
Approaches to Stop Hypertension (DASH) dietary pattern (Lin PH 2003), the daily nitrate intake
easily exceeds 1200 mg/day nitrate. Approximately 25% of ingested nitrate is secreted in saliva, and 
20% of the secreted nitrate in saliva is converted to nitrite by commensal bacteria on the tongue 
(Lundberg JO, 1994), indicating about 5% of the originally ingested nitrate is swallowed into 
stomach (Archer 2002). If you have DASH diet containing 1200 mg nitrate, you are supposed to 
swallow 46 mg nitrite a day. When considering an application of this treatment to clinical practice, 
the amounts of nitrite the mice drank in the present study totaled approximately 0.1 and 0.3 mg/day 
for mouse (the lower dose: 50 mg/L and the higher dose of nitrite: 150 mg/L, respectively, based on 
drinking 2 ml of water/mouse/day). These doses of nitrite (2 and 6 mg/kg/day, calculated as 50 g 
body weight/mouse) could be orally achievable through increasing consumption of nitrate/nitrite-rich 
foods and vegetables (Bryan 2007), providing a possible therapeutic strategy for the diabetic patients. 
Because we have not observed any fetal side effects such as methemoglobinemia and hypotension in 
this mouse model, we have not measured methemoglobin levels and blood pressure. Instead, we 
previously reported a mouse model for experimental colitis treated with 25 mmol/L sodium nitrite in 
drinking water (approximately 35- and 12-fold concentrated nitrite compared to those of the present 
study), whereas even in that doses, no measurable effects on methemoglobin levels and blood 
pressure were observed (Ohtake 2010). Carcinogenesis is another concern attributed to nitrite/nitrate, 
however, today, no causative link between nitrite/nitrate exposure and cancer including stomach 
cancer has been documented in humans (Bryan 2012).
In conclusion, these results suggest that endogenous NO defect might underlie the development of 
insulin resistance, therefore dietary nitrite provides an alternative source of NO, and subsequently
improving insulin-mediated signaling pathway and the metabolic and histological features in KKAy 
diabetic mice.
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Legends
Figure 1
Time course of changes in body weight (A), food intake (B), and fasting blood glucose levels (C)
with or without dietary nitrite.
  ◆ : KKAy-0mg/L, ■: KKAy-50mg/L, ▲: KKAy-150mg/L, ◇ : C57BL/6J-0mg/L, △: 
C57BL/6J-150mg/L. The results are displayed as means ± SE (n=8-10), *P< 0.05 vs.
C57BL/6J-0mg/L.
Figure 2
Effects of dietary nitrite on the time course of blood glucose levels and AUC following IPGTT.
  (A) blood glucose concentrations (mg/mL) following IPGTT, (B) AUC (mg/dL × min) of blood 
glucose following IPGTT. ◆ : KKAy-0mg/L, ■: KKAy-50mg/L, ▲: KKAy-150mg/L, ◇ : 
C57BL/6J-0mg/L, △: C57BL/6J-150mg/L. The results are displayed as means ± SE (n=8-10), *P< 
0.05 vs. KKAy-0 mg/L. AUC: area under the curve (the area under the blood glucose 
concentration-time curve following IPGTT). IPGTT: intraperitoneal glucose tolerance test.
Figure 3
Effects of dietary nitrite on fasting blood levels of glucose and insulin, and insulin sensitivity.
(A) fasting blood glucose, (B) fasting plasma insulin, (C) HOMA-IR score, with or without dietary 
nitrite in KKAy diabetic and C57BL/6J control mice. The results are displayed as means ± SE
(n=8-10), *P< 0.05 vs. KKAy-0mg/L. HOMR-IR: The index of homeostasis model assessment of 
insulin resistance, calculated as fasting plasma glucose [mmol/l] × fasting plasma insulin [mU/l] / 
22.5.  
Figure 4
Effects of dietary nitrite on the morphology of adipose tissues.
  (A) the ratio of adipose tissue mass to body weight (%), (B) area of adipocyte (μm2), The results 
are displayed as means ± SE (n=4-8), *P< 0.05 vs. KKAy-0mg/L. (C) the representative light 
microscopic image of HE-stained adipose tissues of KKAy and C57BL/6J mice with or without 
dietary nitrite (bar: ??? μm), and the distribution histogram of adipocyte size. The area of adipocyte 
was traced and measured in 500 cells/ mouse (n=4/groups) using the Image J software program.
Figure 5
Effects of dietary nitrite on the transcriptional levels of proinflammatory cytokines in visceral 
adipose tissues.
  (A) MCP-1, (B) TNF-α. The data is presented by standard values for levels of GAPDH mRNA 
expression in the adipose tissues studied. The results are displayed as means ± SE (n=6-8), *P<0.05 
vs. KKAy-0mg/L.
Figure 6
Sequential phosphorylation of P85/Akt of skeletal muscle and subsequent expression of GLUT4 on 
the cell membrane of skeletal muscle. 
  The data of western blots are representative of three independent experiments. The band intensities 
of phosphorylation were quantified by comparison to the total protein. (A): p85-Tyr458 to p85 and
(B): Akt-Ser473 to Akt. The band intensities of GLUT4 were also quantified by comparison to 
housekeeping protein GAPDH (C). The results are displayed as means ± SE (n=6-8) *P< 0.05 vs.
KKAy-0mg/L 
Figure 7
Effects of dietary nitrite on the levels of nitrite and nitrate in skeletal muscle.
  The concentrations of nitrite (A) and nitrate (B) in skeletal muscle. The results are displayed as 
means ± SE (n=6-8), *P<0.05 vs. KKAy-0mg/L   
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